Global Enbrel (Etanercept) and Biosimilar Supply, Demand and Key Producers, 2023-2029
The global Enbrel (Etanercept) and Biosimilar market size is expected to reach $ 8122.5 million by 2029, rising at a market growth of 3.2% CAGR during the forecast period (2023-2029).
Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. It is a biologic fusion protein in the TNF blocker class of medications.
This report studies the global Enbrel (Etanercept) and Biosimilar production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Enbrel (Etanercept) and Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Enbrel (Etanercept) and Biosimilar that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Enbrel (Etanercept) and Biosimilar total production and demand, 2018-2029, (K Units)
Global Enbrel (Etanercept) and Biosimilar total production value, 2018-2029, (USD Million)
Global Enbrel (Etanercept) and Biosimilar production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Enbrel (Etanercept) and Biosimilar consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Enbrel (Etanercept) and Biosimilar domestic production, consumption, key domestic manufacturers and share
Global Enbrel (Etanercept) and Biosimilar production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Enbrel (Etanercept) and Biosimilar production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Enbrel (Etanercept) and Biosimilar production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Enbrel (Etanercept) and Biosimilar market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Amgen, Samsung Bioepis, Novartis, 3s Bio and Lupin, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Enbrel (Etanercept) and Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Enbrel (Etanercept) and Biosimilar Market, By Region:
1. How big is the global Enbrel (Etanercept) and Biosimilar market?
2. What is the demand of the global Enbrel (Etanercept) and Biosimilar market?
3. What is the year over year growth of the global Enbrel (Etanercept) and Biosimilar market?
4. What is the production and production value of the global Enbrel (Etanercept) and Biosimilar market?
5. Who are the key producers in the global Enbrel (Etanercept) and Biosimilar market?
6. What are the growth factors driving the market demand?
Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. It is a biologic fusion protein in the TNF blocker class of medications.
This report studies the global Enbrel (Etanercept) and Biosimilar production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Enbrel (Etanercept) and Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Enbrel (Etanercept) and Biosimilar that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Enbrel (Etanercept) and Biosimilar total production and demand, 2018-2029, (K Units)
Global Enbrel (Etanercept) and Biosimilar total production value, 2018-2029, (USD Million)
Global Enbrel (Etanercept) and Biosimilar production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Enbrel (Etanercept) and Biosimilar consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Enbrel (Etanercept) and Biosimilar domestic production, consumption, key domestic manufacturers and share
Global Enbrel (Etanercept) and Biosimilar production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Enbrel (Etanercept) and Biosimilar production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Enbrel (Etanercept) and Biosimilar production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Enbrel (Etanercept) and Biosimilar market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Amgen, Samsung Bioepis, Novartis, 3s Bio and Lupin, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Enbrel (Etanercept) and Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Enbrel (Etanercept) and Biosimilar Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Syringe
- Pen
- Hospital
- Pharmacy
- Other
- Pfizer
- Amgen
- Samsung Bioepis
- Novartis
- 3s Bio
- Lupin
1. How big is the global Enbrel (Etanercept) and Biosimilar market?
2. What is the demand of the global Enbrel (Etanercept) and Biosimilar market?
3. What is the year over year growth of the global Enbrel (Etanercept) and Biosimilar market?
4. What is the production and production value of the global Enbrel (Etanercept) and Biosimilar market?
5. Who are the key producers in the global Enbrel (Etanercept) and Biosimilar market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Enbrel (Etanercept) and Biosimilar Introduction
1.2 World Enbrel (Etanercept) and Biosimilar Supply & Forecast
1.2.1 World Enbrel (Etanercept) and Biosimilar Production Value (2018 & 2022 & 2029)
1.2.2 World Enbrel (Etanercept) and Biosimilar Production (2018-2029)
1.2.3 World Enbrel (Etanercept) and Biosimilar Pricing Trends (2018-2029)
1.3 World Enbrel (Etanercept) and Biosimilar Production by Region (Based on Production Site)
1.3.1 World Enbrel (Etanercept) and Biosimilar Production Value by Region (2018-2029)
1.3.2 World Enbrel (Etanercept) and Biosimilar Production by Region (2018-2029)
1.3.3 World Enbrel (Etanercept) and Biosimilar Average Price by Region (2018-2029)
1.3.4 North America Enbrel (Etanercept) and Biosimilar Production (2018-2029)
1.3.5 Europe Enbrel (Etanercept) and Biosimilar Production (2018-2029)
1.3.6 China Enbrel (Etanercept) and Biosimilar Production (2018-2029)
1.3.7 Japan Enbrel (Etanercept) and Biosimilar Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Enbrel (Etanercept) and Biosimilar Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Enbrel (Etanercept) and Biosimilar Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Enbrel (Etanercept) and Biosimilar Demand (2018-2029)
2.2 World Enbrel (Etanercept) and Biosimilar Consumption by Region
2.2.1 World Enbrel (Etanercept) and Biosimilar Consumption by Region (2018-2023)
2.2.2 World Enbrel (Etanercept) and Biosimilar Consumption Forecast by Region (2024-2029)
2.3 United States Enbrel (Etanercept) and Biosimilar Consumption (2018-2029)
2.4 China Enbrel (Etanercept) and Biosimilar Consumption (2018-2029)
2.5 Europe Enbrel (Etanercept) and Biosimilar Consumption (2018-2029)
2.6 Japan Enbrel (Etanercept) and Biosimilar Consumption (2018-2029)
2.7 South Korea Enbrel (Etanercept) and Biosimilar Consumption (2018-2029)
2.8 ASEAN Enbrel (Etanercept) and Biosimilar Consumption (2018-2029)
2.9 India Enbrel (Etanercept) and Biosimilar Consumption (2018-2029)
3 WORLD ENBREL (ETANERCEPT) AND BIOSIMILAR MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Enbrel (Etanercept) and Biosimilar Production Value by Manufacturer (2018-2023)
3.2 World Enbrel (Etanercept) and Biosimilar Production by Manufacturer (2018-2023)
3.3 World Enbrel (Etanercept) and Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Enbrel (Etanercept) and Biosimilar Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Enbrel (Etanercept) and Biosimilar Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Enbrel (Etanercept) and Biosimilar in 2022
3.5.3 Global Concentration Ratios (CR8) for Enbrel (Etanercept) and Biosimilar in 2022
3.6 Enbrel (Etanercept) and Biosimilar Market: Overall Company Footprint Analysis
3.6.1 Enbrel (Etanercept) and Biosimilar Market: Region Footprint
3.6.2 Enbrel (Etanercept) and Biosimilar Market: Company Product Type Footprint
3.6.3 Enbrel (Etanercept) and Biosimilar Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Enbrel (Etanercept) and Biosimilar Production Value Comparison
4.1.1 United States VS China: Enbrel (Etanercept) and Biosimilar Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Enbrel (Etanercept) and Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Enbrel (Etanercept) and Biosimilar Production Comparison
4.2.1 United States VS China: Enbrel (Etanercept) and Biosimilar Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Enbrel (Etanercept) and Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Enbrel (Etanercept) and Biosimilar Consumption Comparison
4.3.1 United States VS China: Enbrel (Etanercept) and Biosimilar Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Enbrel (Etanercept) and Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Enbrel (Etanercept) and Biosimilar Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Enbrel (Etanercept) and Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value (2018-2023)
4.4.3 United States Based Manufacturers Enbrel (Etanercept) and Biosimilar Production (2018-2023)
4.5 China Based Enbrel (Etanercept) and Biosimilar Manufacturers and Market Share
4.5.1 China Based Enbrel (Etanercept) and Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value (2018-2023)
4.5.3 China Based Manufacturers Enbrel (Etanercept) and Biosimilar Production (2018-2023)
4.6 Rest of World Based Enbrel (Etanercept) and Biosimilar Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Enbrel (Etanercept) and Biosimilar Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Enbrel (Etanercept) and Biosimilar Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Enbrel (Etanercept) and Biosimilar Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Syringe
5.2.2 Pen
5.3 Market Segment by Type
5.3.1 World Enbrel (Etanercept) and Biosimilar Production by Type (2018-2029)
5.3.2 World Enbrel (Etanercept) and Biosimilar Production Value by Type (2018-2029)
5.3.3 World Enbrel (Etanercept) and Biosimilar Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Enbrel (Etanercept) and Biosimilar Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Pharmacy
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Enbrel (Etanercept) and Biosimilar Production by Application (2018-2029)
6.3.2 World Enbrel (Etanercept) and Biosimilar Production Value by Application (2018-2029)
6.3.3 World Enbrel (Etanercept) and Biosimilar Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Enbrel (Etanercept) and Biosimilar Product and Services
7.1.4 Pfizer Enbrel (Etanercept) and Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Enbrel (Etanercept) and Biosimilar Product and Services
7.2.4 Amgen Enbrel (Etanercept) and Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 Samsung Bioepis
7.3.1 Samsung Bioepis Details
7.3.2 Samsung Bioepis Major Business
7.3.3 Samsung Bioepis Enbrel (Etanercept) and Biosimilar Product and Services
7.3.4 Samsung Bioepis Enbrel (Etanercept) and Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Samsung Bioepis Recent Developments/Updates
7.3.6 Samsung Bioepis Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Enbrel (Etanercept) and Biosimilar Product and Services
7.4.4 Novartis Enbrel (Etanercept) and Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 3s Bio
7.5.1 3s Bio Details
7.5.2 3s Bio Major Business
7.5.3 3s Bio Enbrel (Etanercept) and Biosimilar Product and Services
7.5.4 3s Bio Enbrel (Etanercept) and Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 3s Bio Recent Developments/Updates
7.5.6 3s Bio Competitive Strengths & Weaknesses
7.6 Lupin
7.6.1 Lupin Details
7.6.2 Lupin Major Business
7.6.3 Lupin Enbrel (Etanercept) and Biosimilar Product and Services
7.6.4 Lupin Enbrel (Etanercept) and Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Lupin Recent Developments/Updates
7.6.6 Lupin Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Enbrel (Etanercept) and Biosimilar Industry Chain
8.2 Enbrel (Etanercept) and Biosimilar Upstream Analysis
8.2.1 Enbrel (Etanercept) and Biosimilar Core Raw Materials
8.2.2 Main Manufacturers of Enbrel (Etanercept) and Biosimilar Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Enbrel (Etanercept) and Biosimilar Production Mode
8.6 Enbrel (Etanercept) and Biosimilar Procurement Model
8.7 Enbrel (Etanercept) and Biosimilar Industry Sales Model and Sales Channels
8.7.1 Enbrel (Etanercept) and Biosimilar Sales Model
8.7.2 Enbrel (Etanercept) and Biosimilar Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Enbrel (Etanercept) and Biosimilar Introduction
1.2 World Enbrel (Etanercept) and Biosimilar Supply & Forecast
1.2.1 World Enbrel (Etanercept) and Biosimilar Production Value (2018 & 2022 & 2029)
1.2.2 World Enbrel (Etanercept) and Biosimilar Production (2018-2029)
1.2.3 World Enbrel (Etanercept) and Biosimilar Pricing Trends (2018-2029)
1.3 World Enbrel (Etanercept) and Biosimilar Production by Region (Based on Production Site)
1.3.1 World Enbrel (Etanercept) and Biosimilar Production Value by Region (2018-2029)
1.3.2 World Enbrel (Etanercept) and Biosimilar Production by Region (2018-2029)
1.3.3 World Enbrel (Etanercept) and Biosimilar Average Price by Region (2018-2029)
1.3.4 North America Enbrel (Etanercept) and Biosimilar Production (2018-2029)
1.3.5 Europe Enbrel (Etanercept) and Biosimilar Production (2018-2029)
1.3.6 China Enbrel (Etanercept) and Biosimilar Production (2018-2029)
1.3.7 Japan Enbrel (Etanercept) and Biosimilar Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Enbrel (Etanercept) and Biosimilar Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Enbrel (Etanercept) and Biosimilar Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Enbrel (Etanercept) and Biosimilar Demand (2018-2029)
2.2 World Enbrel (Etanercept) and Biosimilar Consumption by Region
2.2.1 World Enbrel (Etanercept) and Biosimilar Consumption by Region (2018-2023)
2.2.2 World Enbrel (Etanercept) and Biosimilar Consumption Forecast by Region (2024-2029)
2.3 United States Enbrel (Etanercept) and Biosimilar Consumption (2018-2029)
2.4 China Enbrel (Etanercept) and Biosimilar Consumption (2018-2029)
2.5 Europe Enbrel (Etanercept) and Biosimilar Consumption (2018-2029)
2.6 Japan Enbrel (Etanercept) and Biosimilar Consumption (2018-2029)
2.7 South Korea Enbrel (Etanercept) and Biosimilar Consumption (2018-2029)
2.8 ASEAN Enbrel (Etanercept) and Biosimilar Consumption (2018-2029)
2.9 India Enbrel (Etanercept) and Biosimilar Consumption (2018-2029)
3 WORLD ENBREL (ETANERCEPT) AND BIOSIMILAR MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Enbrel (Etanercept) and Biosimilar Production Value by Manufacturer (2018-2023)
3.2 World Enbrel (Etanercept) and Biosimilar Production by Manufacturer (2018-2023)
3.3 World Enbrel (Etanercept) and Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Enbrel (Etanercept) and Biosimilar Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Enbrel (Etanercept) and Biosimilar Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Enbrel (Etanercept) and Biosimilar in 2022
3.5.3 Global Concentration Ratios (CR8) for Enbrel (Etanercept) and Biosimilar in 2022
3.6 Enbrel (Etanercept) and Biosimilar Market: Overall Company Footprint Analysis
3.6.1 Enbrel (Etanercept) and Biosimilar Market: Region Footprint
3.6.2 Enbrel (Etanercept) and Biosimilar Market: Company Product Type Footprint
3.6.3 Enbrel (Etanercept) and Biosimilar Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Enbrel (Etanercept) and Biosimilar Production Value Comparison
4.1.1 United States VS China: Enbrel (Etanercept) and Biosimilar Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Enbrel (Etanercept) and Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Enbrel (Etanercept) and Biosimilar Production Comparison
4.2.1 United States VS China: Enbrel (Etanercept) and Biosimilar Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Enbrel (Etanercept) and Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Enbrel (Etanercept) and Biosimilar Consumption Comparison
4.3.1 United States VS China: Enbrel (Etanercept) and Biosimilar Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Enbrel (Etanercept) and Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Enbrel (Etanercept) and Biosimilar Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Enbrel (Etanercept) and Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value (2018-2023)
4.4.3 United States Based Manufacturers Enbrel (Etanercept) and Biosimilar Production (2018-2023)
4.5 China Based Enbrel (Etanercept) and Biosimilar Manufacturers and Market Share
4.5.1 China Based Enbrel (Etanercept) and Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value (2018-2023)
4.5.3 China Based Manufacturers Enbrel (Etanercept) and Biosimilar Production (2018-2023)
4.6 Rest of World Based Enbrel (Etanercept) and Biosimilar Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Enbrel (Etanercept) and Biosimilar Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Enbrel (Etanercept) and Biosimilar Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Enbrel (Etanercept) and Biosimilar Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Syringe
5.2.2 Pen
5.3 Market Segment by Type
5.3.1 World Enbrel (Etanercept) and Biosimilar Production by Type (2018-2029)
5.3.2 World Enbrel (Etanercept) and Biosimilar Production Value by Type (2018-2029)
5.3.3 World Enbrel (Etanercept) and Biosimilar Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Enbrel (Etanercept) and Biosimilar Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Pharmacy
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Enbrel (Etanercept) and Biosimilar Production by Application (2018-2029)
6.3.2 World Enbrel (Etanercept) and Biosimilar Production Value by Application (2018-2029)
6.3.3 World Enbrel (Etanercept) and Biosimilar Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Enbrel (Etanercept) and Biosimilar Product and Services
7.1.4 Pfizer Enbrel (Etanercept) and Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Enbrel (Etanercept) and Biosimilar Product and Services
7.2.4 Amgen Enbrel (Etanercept) and Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 Samsung Bioepis
7.3.1 Samsung Bioepis Details
7.3.2 Samsung Bioepis Major Business
7.3.3 Samsung Bioepis Enbrel (Etanercept) and Biosimilar Product and Services
7.3.4 Samsung Bioepis Enbrel (Etanercept) and Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Samsung Bioepis Recent Developments/Updates
7.3.6 Samsung Bioepis Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Enbrel (Etanercept) and Biosimilar Product and Services
7.4.4 Novartis Enbrel (Etanercept) and Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 3s Bio
7.5.1 3s Bio Details
7.5.2 3s Bio Major Business
7.5.3 3s Bio Enbrel (Etanercept) and Biosimilar Product and Services
7.5.4 3s Bio Enbrel (Etanercept) and Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 3s Bio Recent Developments/Updates
7.5.6 3s Bio Competitive Strengths & Weaknesses
7.6 Lupin
7.6.1 Lupin Details
7.6.2 Lupin Major Business
7.6.3 Lupin Enbrel (Etanercept) and Biosimilar Product and Services
7.6.4 Lupin Enbrel (Etanercept) and Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Lupin Recent Developments/Updates
7.6.6 Lupin Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Enbrel (Etanercept) and Biosimilar Industry Chain
8.2 Enbrel (Etanercept) and Biosimilar Upstream Analysis
8.2.1 Enbrel (Etanercept) and Biosimilar Core Raw Materials
8.2.2 Main Manufacturers of Enbrel (Etanercept) and Biosimilar Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Enbrel (Etanercept) and Biosimilar Production Mode
8.6 Enbrel (Etanercept) and Biosimilar Procurement Model
8.7 Enbrel (Etanercept) and Biosimilar Industry Sales Model and Sales Channels
8.7.1 Enbrel (Etanercept) and Biosimilar Sales Model
8.7.2 Enbrel (Etanercept) and Biosimilar Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Enbrel (Etanercept) and Biosimilar Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Enbrel (Etanercept) and Biosimilar Production Value by Region (2018-2023) & (USD Million)
Table 3. World Enbrel (Etanercept) and Biosimilar Production Value by Region (2024-2029) & (USD Million)
Table 4. World Enbrel (Etanercept) and Biosimilar Production Value Market Share by Region (2018-2023)
Table 5. World Enbrel (Etanercept) and Biosimilar Production Value Market Share by Region (2024-2029)
Table 6. World Enbrel (Etanercept) and Biosimilar Production by Region (2018-2023) & (K Units)
Table 7. World Enbrel (Etanercept) and Biosimilar Production by Region (2024-2029) & (K Units)
Table 8. World Enbrel (Etanercept) and Biosimilar Production Market Share by Region (2018-2023)
Table 9. World Enbrel (Etanercept) and Biosimilar Production Market Share by Region (2024-2029)
Table 10. World Enbrel (Etanercept) and Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Enbrel (Etanercept) and Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Enbrel (Etanercept) and Biosimilar Major Market Trends
Table 13. World Enbrel (Etanercept) and Biosimilar Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Enbrel (Etanercept) and Biosimilar Consumption by Region (2018-2023) & (K Units)
Table 15. World Enbrel (Etanercept) and Biosimilar Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Enbrel (Etanercept) and Biosimilar Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Enbrel (Etanercept) and Biosimilar Producers in 2022
Table 18. World Enbrel (Etanercept) and Biosimilar Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Enbrel (Etanercept) and Biosimilar Producers in 2022
Table 20. World Enbrel (Etanercept) and Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Enbrel (Etanercept) and Biosimilar Company Evaluation Quadrant
Table 22. World Enbrel (Etanercept) and Biosimilar Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Enbrel (Etanercept) and Biosimilar Production Site of Key Manufacturer
Table 24. Enbrel (Etanercept) and Biosimilar Market: Company Product Type Footprint
Table 25. Enbrel (Etanercept) and Biosimilar Market: Company Product Application Footprint
Table 26. Enbrel (Etanercept) and Biosimilar Competitive Factors
Table 27. Enbrel (Etanercept) and Biosimilar New Entrant and Capacity Expansion Plans
Table 28. Enbrel (Etanercept) and Biosimilar Mergers & Acquisitions Activity
Table 29. United States VS China Enbrel (Etanercept) and Biosimilar Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Enbrel (Etanercept) and Biosimilar Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Enbrel (Etanercept) and Biosimilar Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Enbrel (Etanercept) and Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Enbrel (Etanercept) and Biosimilar Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Market Share (2018-2023)
Table 37. China Based Enbrel (Etanercept) and Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Enbrel (Etanercept) and Biosimilar Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Market Share (2018-2023)
Table 42. Rest of World Based Enbrel (Etanercept) and Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Enbrel (Etanercept) and Biosimilar Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Market Share (2018-2023)
Table 47. World Enbrel (Etanercept) and Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Enbrel (Etanercept) and Biosimilar Production by Type (2018-2023) & (K Units)
Table 49. World Enbrel (Etanercept) and Biosimilar Production by Type (2024-2029) & (K Units)
Table 50. World Enbrel (Etanercept) and Biosimilar Production Value by Type (2018-2023) & (USD Million)
Table 51. World Enbrel (Etanercept) and Biosimilar Production Value by Type (2024-2029) & (USD Million)
Table 52. World Enbrel (Etanercept) and Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Enbrel (Etanercept) and Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Enbrel (Etanercept) and Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Enbrel (Etanercept) and Biosimilar Production by Application (2018-2023) & (K Units)
Table 56. World Enbrel (Etanercept) and Biosimilar Production by Application (2024-2029) & (K Units)
Table 57. World Enbrel (Etanercept) and Biosimilar Production Value by Application (2018-2023) & (USD Million)
Table 58. World Enbrel (Etanercept) and Biosimilar Production Value by Application (2024-2029) & (USD Million)
Table 59. World Enbrel (Etanercept) and Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Enbrel (Etanercept) and Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Enbrel (Etanercept) and Biosimilar Product and Services
Table 64. Pfizer Enbrel (Etanercept) and Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Amgen Basic Information, Manufacturing Base and Competitors
Table 68. Amgen Major Business
Table 69. Amgen Enbrel (Etanercept) and Biosimilar Product and Services
Table 70. Amgen Enbrel (Etanercept) and Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Amgen Recent Developments/Updates
Table 72. Amgen Competitive Strengths & Weaknesses
Table 73. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 74. Samsung Bioepis Major Business
Table 75. Samsung Bioepis Enbrel (Etanercept) and Biosimilar Product and Services
Table 76. Samsung Bioepis Enbrel (Etanercept) and Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Samsung Bioepis Recent Developments/Updates
Table 78. Samsung Bioepis Competitive Strengths & Weaknesses
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Enbrel (Etanercept) and Biosimilar Product and Services
Table 82. Novartis Enbrel (Etanercept) and Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Novartis Recent Developments/Updates
Table 84. Novartis Competitive Strengths & Weaknesses
Table 85. 3s Bio Basic Information, Manufacturing Base and Competitors
Table 86. 3s Bio Major Business
Table 87. 3s Bio Enbrel (Etanercept) and Biosimilar Product and Services
Table 88. 3s Bio Enbrel (Etanercept) and Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. 3s Bio Recent Developments/Updates
Table 90. Lupin Basic Information, Manufacturing Base and Competitors
Table 91. Lupin Major Business
Table 92. Lupin Enbrel (Etanercept) and Biosimilar Product and Services
Table 93. Lupin Enbrel (Etanercept) and Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Global Key Players of Enbrel (Etanercept) and Biosimilar Upstream (Raw Materials)
Table 95. Enbrel (Etanercept) and Biosimilar Typical Customers
Table 96. Enbrel (Etanercept) and Biosimilar Typical Distributors
Table 1. World Enbrel (Etanercept) and Biosimilar Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Enbrel (Etanercept) and Biosimilar Production Value by Region (2018-2023) & (USD Million)
Table 3. World Enbrel (Etanercept) and Biosimilar Production Value by Region (2024-2029) & (USD Million)
Table 4. World Enbrel (Etanercept) and Biosimilar Production Value Market Share by Region (2018-2023)
Table 5. World Enbrel (Etanercept) and Biosimilar Production Value Market Share by Region (2024-2029)
Table 6. World Enbrel (Etanercept) and Biosimilar Production by Region (2018-2023) & (K Units)
Table 7. World Enbrel (Etanercept) and Biosimilar Production by Region (2024-2029) & (K Units)
Table 8. World Enbrel (Etanercept) and Biosimilar Production Market Share by Region (2018-2023)
Table 9. World Enbrel (Etanercept) and Biosimilar Production Market Share by Region (2024-2029)
Table 10. World Enbrel (Etanercept) and Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Enbrel (Etanercept) and Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Enbrel (Etanercept) and Biosimilar Major Market Trends
Table 13. World Enbrel (Etanercept) and Biosimilar Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Enbrel (Etanercept) and Biosimilar Consumption by Region (2018-2023) & (K Units)
Table 15. World Enbrel (Etanercept) and Biosimilar Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Enbrel (Etanercept) and Biosimilar Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Enbrel (Etanercept) and Biosimilar Producers in 2022
Table 18. World Enbrel (Etanercept) and Biosimilar Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Enbrel (Etanercept) and Biosimilar Producers in 2022
Table 20. World Enbrel (Etanercept) and Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Enbrel (Etanercept) and Biosimilar Company Evaluation Quadrant
Table 22. World Enbrel (Etanercept) and Biosimilar Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Enbrel (Etanercept) and Biosimilar Production Site of Key Manufacturer
Table 24. Enbrel (Etanercept) and Biosimilar Market: Company Product Type Footprint
Table 25. Enbrel (Etanercept) and Biosimilar Market: Company Product Application Footprint
Table 26. Enbrel (Etanercept) and Biosimilar Competitive Factors
Table 27. Enbrel (Etanercept) and Biosimilar New Entrant and Capacity Expansion Plans
Table 28. Enbrel (Etanercept) and Biosimilar Mergers & Acquisitions Activity
Table 29. United States VS China Enbrel (Etanercept) and Biosimilar Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Enbrel (Etanercept) and Biosimilar Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Enbrel (Etanercept) and Biosimilar Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Enbrel (Etanercept) and Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Enbrel (Etanercept) and Biosimilar Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Market Share (2018-2023)
Table 37. China Based Enbrel (Etanercept) and Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Enbrel (Etanercept) and Biosimilar Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Market Share (2018-2023)
Table 42. Rest of World Based Enbrel (Etanercept) and Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Enbrel (Etanercept) and Biosimilar Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Market Share (2018-2023)
Table 47. World Enbrel (Etanercept) and Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Enbrel (Etanercept) and Biosimilar Production by Type (2018-2023) & (K Units)
Table 49. World Enbrel (Etanercept) and Biosimilar Production by Type (2024-2029) & (K Units)
Table 50. World Enbrel (Etanercept) and Biosimilar Production Value by Type (2018-2023) & (USD Million)
Table 51. World Enbrel (Etanercept) and Biosimilar Production Value by Type (2024-2029) & (USD Million)
Table 52. World Enbrel (Etanercept) and Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Enbrel (Etanercept) and Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Enbrel (Etanercept) and Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Enbrel (Etanercept) and Biosimilar Production by Application (2018-2023) & (K Units)
Table 56. World Enbrel (Etanercept) and Biosimilar Production by Application (2024-2029) & (K Units)
Table 57. World Enbrel (Etanercept) and Biosimilar Production Value by Application (2018-2023) & (USD Million)
Table 58. World Enbrel (Etanercept) and Biosimilar Production Value by Application (2024-2029) & (USD Million)
Table 59. World Enbrel (Etanercept) and Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Enbrel (Etanercept) and Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Enbrel (Etanercept) and Biosimilar Product and Services
Table 64. Pfizer Enbrel (Etanercept) and Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Amgen Basic Information, Manufacturing Base and Competitors
Table 68. Amgen Major Business
Table 69. Amgen Enbrel (Etanercept) and Biosimilar Product and Services
Table 70. Amgen Enbrel (Etanercept) and Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Amgen Recent Developments/Updates
Table 72. Amgen Competitive Strengths & Weaknesses
Table 73. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 74. Samsung Bioepis Major Business
Table 75. Samsung Bioepis Enbrel (Etanercept) and Biosimilar Product and Services
Table 76. Samsung Bioepis Enbrel (Etanercept) and Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Samsung Bioepis Recent Developments/Updates
Table 78. Samsung Bioepis Competitive Strengths & Weaknesses
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Enbrel (Etanercept) and Biosimilar Product and Services
Table 82. Novartis Enbrel (Etanercept) and Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Novartis Recent Developments/Updates
Table 84. Novartis Competitive Strengths & Weaknesses
Table 85. 3s Bio Basic Information, Manufacturing Base and Competitors
Table 86. 3s Bio Major Business
Table 87. 3s Bio Enbrel (Etanercept) and Biosimilar Product and Services
Table 88. 3s Bio Enbrel (Etanercept) and Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. 3s Bio Recent Developments/Updates
Table 90. Lupin Basic Information, Manufacturing Base and Competitors
Table 91. Lupin Major Business
Table 92. Lupin Enbrel (Etanercept) and Biosimilar Product and Services
Table 93. Lupin Enbrel (Etanercept) and Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Global Key Players of Enbrel (Etanercept) and Biosimilar Upstream (Raw Materials)
Table 95. Enbrel (Etanercept) and Biosimilar Typical Customers
Table 96. Enbrel (Etanercept) and Biosimilar Typical Distributors
LIST OF FIGURES
Figure 1. Enbrel (Etanercept) and Biosimilar Picture
Figure 2. World Enbrel (Etanercept) and Biosimilar Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Enbrel (Etanercept) and Biosimilar Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Enbrel (Etanercept) and Biosimilar Production (2018-2029) & (K Units)
Figure 5. World Enbrel (Etanercept) and Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 6. World Enbrel (Etanercept) and Biosimilar Production Value Market Share by Region (2018-2029)
Figure 7. World Enbrel (Etanercept) and Biosimilar Production Market Share by Region (2018-2029)
Figure 8. North America Enbrel (Etanercept) and Biosimilar Production (2018-2029) & (K Units)
Figure 9. Europe Enbrel (Etanercept) and Biosimilar Production (2018-2029) & (K Units)
Figure 10. China Enbrel (Etanercept) and Biosimilar Production (2018-2029) & (K Units)
Figure 11. Japan Enbrel (Etanercept) and Biosimilar Production (2018-2029) & (K Units)
Figure 12. Enbrel (Etanercept) and Biosimilar Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Enbrel (Etanercept) and Biosimilar Consumption (2018-2029) & (K Units)
Figure 15. World Enbrel (Etanercept) and Biosimilar Consumption Market Share by Region (2018-2029)
Figure 16. United States Enbrel (Etanercept) and Biosimilar Consumption (2018-2029) & (K Units)
Figure 17. China Enbrel (Etanercept) and Biosimilar Consumption (2018-2029) & (K Units)
Figure 18. Europe Enbrel (Etanercept) and Biosimilar Consumption (2018-2029) & (K Units)
Figure 19. Japan Enbrel (Etanercept) and Biosimilar Consumption (2018-2029) & (K Units)
Figure 20. South Korea Enbrel (Etanercept) and Biosimilar Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Enbrel (Etanercept) and Biosimilar Consumption (2018-2029) & (K Units)
Figure 22. India Enbrel (Etanercept) and Biosimilar Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Enbrel (Etanercept) and Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Enbrel (Etanercept) and Biosimilar Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Enbrel (Etanercept) and Biosimilar Markets in 2022
Figure 26. United States VS China: Enbrel (Etanercept) and Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Enbrel (Etanercept) and Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Enbrel (Etanercept) and Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Market Share 2022
Figure 30. China Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Market Share 2022
Figure 32. World Enbrel (Etanercept) and Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Enbrel (Etanercept) and Biosimilar Production Value Market Share by Type in 2022
Figure 34. Syringe
Figure 35. Pen
Figure 36. World Enbrel (Etanercept) and Biosimilar Production Market Share by Type (2018-2029)
Figure 37. World Enbrel (Etanercept) and Biosimilar Production Value Market Share by Type (2018-2029)
Figure 38. World Enbrel (Etanercept) and Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Enbrel (Etanercept) and Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Enbrel (Etanercept) and Biosimilar Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Pharmacy
Figure 43. Other
Figure 44. World Enbrel (Etanercept) and Biosimilar Production Market Share by Application (2018-2029)
Figure 45. World Enbrel (Etanercept) and Biosimilar Production Value Market Share by Application (2018-2029)
Figure 46. World Enbrel (Etanercept) and Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Enbrel (Etanercept) and Biosimilar Industry Chain
Figure 48. Enbrel (Etanercept) and Biosimilar Procurement Model
Figure 49. Enbrel (Etanercept) and Biosimilar Sales Model
Figure 50. Enbrel (Etanercept) and Biosimilar Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Enbrel (Etanercept) and Biosimilar Picture
Figure 2. World Enbrel (Etanercept) and Biosimilar Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Enbrel (Etanercept) and Biosimilar Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Enbrel (Etanercept) and Biosimilar Production (2018-2029) & (K Units)
Figure 5. World Enbrel (Etanercept) and Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 6. World Enbrel (Etanercept) and Biosimilar Production Value Market Share by Region (2018-2029)
Figure 7. World Enbrel (Etanercept) and Biosimilar Production Market Share by Region (2018-2029)
Figure 8. North America Enbrel (Etanercept) and Biosimilar Production (2018-2029) & (K Units)
Figure 9. Europe Enbrel (Etanercept) and Biosimilar Production (2018-2029) & (K Units)
Figure 10. China Enbrel (Etanercept) and Biosimilar Production (2018-2029) & (K Units)
Figure 11. Japan Enbrel (Etanercept) and Biosimilar Production (2018-2029) & (K Units)
Figure 12. Enbrel (Etanercept) and Biosimilar Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Enbrel (Etanercept) and Biosimilar Consumption (2018-2029) & (K Units)
Figure 15. World Enbrel (Etanercept) and Biosimilar Consumption Market Share by Region (2018-2029)
Figure 16. United States Enbrel (Etanercept) and Biosimilar Consumption (2018-2029) & (K Units)
Figure 17. China Enbrel (Etanercept) and Biosimilar Consumption (2018-2029) & (K Units)
Figure 18. Europe Enbrel (Etanercept) and Biosimilar Consumption (2018-2029) & (K Units)
Figure 19. Japan Enbrel (Etanercept) and Biosimilar Consumption (2018-2029) & (K Units)
Figure 20. South Korea Enbrel (Etanercept) and Biosimilar Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Enbrel (Etanercept) and Biosimilar Consumption (2018-2029) & (K Units)
Figure 22. India Enbrel (Etanercept) and Biosimilar Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Enbrel (Etanercept) and Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Enbrel (Etanercept) and Biosimilar Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Enbrel (Etanercept) and Biosimilar Markets in 2022
Figure 26. United States VS China: Enbrel (Etanercept) and Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Enbrel (Etanercept) and Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Enbrel (Etanercept) and Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Market Share 2022
Figure 30. China Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Enbrel (Etanercept) and Biosimilar Production Market Share 2022
Figure 32. World Enbrel (Etanercept) and Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Enbrel (Etanercept) and Biosimilar Production Value Market Share by Type in 2022
Figure 34. Syringe
Figure 35. Pen
Figure 36. World Enbrel (Etanercept) and Biosimilar Production Market Share by Type (2018-2029)
Figure 37. World Enbrel (Etanercept) and Biosimilar Production Value Market Share by Type (2018-2029)
Figure 38. World Enbrel (Etanercept) and Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Enbrel (Etanercept) and Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Enbrel (Etanercept) and Biosimilar Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Pharmacy
Figure 43. Other
Figure 44. World Enbrel (Etanercept) and Biosimilar Production Market Share by Application (2018-2029)
Figure 45. World Enbrel (Etanercept) and Biosimilar Production Value Market Share by Application (2018-2029)
Figure 46. World Enbrel (Etanercept) and Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Enbrel (Etanercept) and Biosimilar Industry Chain
Figure 48. Enbrel (Etanercept) and Biosimilar Procurement Model
Figure 49. Enbrel (Etanercept) and Biosimilar Sales Model
Figure 50. Enbrel (Etanercept) and Biosimilar Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
